AdvaMed’s Diagnostic Supply Registry is tracking the progress of molecular diagnostic tests to help support state and federal governments.
Vulnerability sharing arms stakeholders with the information they need to assess devices, minimize cybersecurity risks and proactively mitigate emerging risks to prevent exploitation.
AdvaMed has reported that its member companies have provided $26.8 million in medical supplies, along with $4.1 million in cash donations.
A product malfunction could cause potential over-infusion or unintended delivery of medication.
The agency found several violations during an inspection related to its investigation of inaccurate blood lead test results.